{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T10:09:41Z","timestamp":1760954981097},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,5,1]],"date-time":"2007-05-01T00:00:00Z","timestamp":1177977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2007,5]]},"DOI":"10.1016\/j.ejca.2007.03.001","type":"journal-article","created":{"date-parts":[[2007,4,17]],"date-time":"2007-04-17T11:17:27Z","timestamp":1176808647000},"page":"1251-1256","source":"Crossref","is-referenced-by-count":12,"title":["Sulindac treatment in hereditary non-polyposis colorectal cancer"],"prefix":"10.1016","volume":"43","author":[{"given":"Fleur E.M.","family":"Rijcken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry","family":"Hollema","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ate G.J.","family":"van der Zee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tineke","family":"van der Sluis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wytske","family":"Boersma-van Ek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan H.","family":"Kleibeuker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2007.03.001_bib1","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1056\/NEJMra012242","article-title":"Hereditary colorectal cancer","volume":"348","author":"Lynch","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2007.03.001_bib2","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0092-8674(00)81333-1","article-title":"Lessons from hereditary colorectal cancer","volume":"87","author":"Kinzler","year":"1996","journal-title":"Cell"},{"key":"10.1016\/j.ejca.2007.03.001_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0006-2952(96)00181-5","article-title":"Effects of nonsteroidal anti-inflammatory drugs on proliferation and on induction of apoptosis in colon cancer cells by a prostaglandin-independent pathway","volume":"52","author":"Hanif","year":"1996","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.ejca.2007.03.001_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1136\/gut.48.5.660","article-title":"Non-steroidal anti-inflammatory drugs with activity against either cyclooxygenase 1 or cyclooxygenase 2 inhibit colorectal cancer in a DMH rodent model by inducing apoptosis and inhibiting cell proliferation","volume":"48","author":"Brown","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.ejca.2007.03.001_bib5","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJM199305063281805","article-title":"Treatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis","volume":"328","author":"Giardiello","year":"1993","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2007.03.001_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1056\/NEJMoa021735","article-title":"A randomized trial of aspirin to prevent colorectal adenomas","volume":"348","author":"Baron","year":"2003","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2007.03.001_bib7","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1056\/NEJM200006293422606","article-title":"Chemoprevention of colorectal cancer","volume":"342","author":"Janne","year":"2000","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2007.03.001_bib8","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/jnci\/94.4.252","article-title":"Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues","volume":"94","author":"Thun","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.ejca.2007.03.001_bib9","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1053\/gast.2002.31890","article-title":"Long-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study","volume":"122","author":"Cruz-Correa","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2007.03.001_bib10","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1056\/NEJM199509073331001","article-title":"Aspirin and the risk of colorectal cancer in women","volume":"333","author":"Giovannucci","year":"1995","journal-title":"New Engl J Med"},{"key":"10.1016\/j.ejca.2007.03.001_bib11","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/0016-5085(91)90519-Q","article-title":"Sulindac causes regression of rectal polyps in familial adenomatous polyposis","volume":"101","author":"Labayle","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2007.03.001_bib12","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1172\/JCI118060","article-title":"Sulindac sulfide, an aspirin-like compound, inhibits proliferation, causes cell cycle quiescence, and induces apoptosis in HT-29 colon adenocarcinoma cells","volume":"96","author":"Shiff","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ejca.2007.03.001_bib13","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1006\/excr.1996.0023","article-title":"Nonsteroidal antiinflammatory drugs inhibit the proliferation of colon adenocarcinoma cells: effects on cell cycle and apoptosis","volume":"22","author":"Shiff","year":"1996","journal-title":"Exp Cell Res"},{"key":"10.1016\/j.ejca.2007.03.001_bib14","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1470-2045(01)00488-0","article-title":"Cyclo-oxygenase 2: a pharmacological target for the prevention of cancer","volume":"2","author":"Dannenberg","year":"2001","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2007.03.001_bib15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/(SICI)1097-0215(19980330)76:1<99::AID-IJC16>3.0.CO;2-B","article-title":"Sulindac sulfide alters the expression of cyclin proteins in HT-29 colon adenocarcinoma cells","volume":"76","author":"Qiao","year":"1998","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ejca.2007.03.001_bib16","doi-asserted-by":"crossref","first-page":"931","DOI":"10.4161\/cc.3.7.971","article-title":"Induction of transcription by p21Waf1\/Cip1\/Sdi1: role of NFkappaB and effect of non-steroidal anti-inflammatory drugs","volume":"3","author":"Poole","year":"2004","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejca.2007.03.001_bib17","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1126\/science.290.5493.989","article-title":"Role of BAX in the apoptotic response to anticancer agents","volume":"290","author":"Zhang","year":"2000","journal-title":"Science"},{"key":"10.1016\/j.ejca.2007.03.001_bib18","first-page":"6297","article-title":"p21(WAF1\/cip1) is an important determinant of intestinal cell response to sulindac in vitro and in vivo","volume":"61","author":"Yang","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejca.2007.03.001_bib19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/BF02053699","article-title":"The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC)","volume":"34","author":"Vasen","year":"1991","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejca.2007.03.001_bib20","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0016-5085(99)70510-X","article-title":"New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC","volume":"116","author":"Vasen","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2007.03.001_bib21","first-page":"893","article-title":"The anti-proliferative effect of sulindac and sulindac sulfide on HT-29 colon cancer cells: alterations in tumor suppressor and cell cycle-regulatory proteins","volume":"12","author":"Goldberg","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.ejca.2007.03.001_bib22","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1002\/bjs.1800801244","article-title":"Randomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis","volume":"80","author":"Nugent","year":"1993","journal-title":"Br J Surg"},{"key":"10.1016\/j.ejca.2007.03.001_bib23","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0016-5085(94)90593-2","article-title":"Rectal proliferation and polyp occurrence in patients with familial adenomatous polyposis after sulindac treatment","volume":"106","author":"Spagnesi","year":"1994","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2007.03.001_bib24","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1016\/0016-5085(95)90411-5","article-title":"The effects of sulindac on colorectal proliferation and apoptosis in familial adenomatous polyposis","volume":"109","author":"Pasricha","year":"1995","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ejca.2007.03.001_bib25","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/BF02055161","article-title":"Clinical and genomic influence of sulindac on rectal mucosa in familial adenomatous polyposis","volume":"40","author":"Winde","year":"1997","journal-title":"Dis Colon Rectum"},{"key":"10.1016\/j.ejca.2007.03.001_bib26","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2184.1998.00111.x","article-title":"Sulindac enhances cell proliferation in DMH-treated mouse colonic mucosa","volume":"31","author":"Moorghen","year":"1998","journal-title":"Cell Prolif"},{"key":"10.1016\/j.ejca.2007.03.001_bib27","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1136\/gut.45.6.822","article-title":"Rectal epithelial apoptosis in familial adenomatous polyposis patients treated with sulindac","volume":"45","author":"Keller","year":"1999","journal-title":"Gut"},{"key":"10.1016\/j.ejca.2007.03.001_bib28","first-page":"670","article-title":"Rectal epithelial apoptosis does not predict response to sulindac treatment or polyp development in presymptomatic familial adenomatous polyposis patients","volume":"11","author":"Keller","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804907001979?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804907001979?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,8]],"date-time":"2019-01-08T07:20:19Z","timestamp":1546932019000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804907001979"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,5]]}},"alternative-id":["S0959804907001979"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2007.03.001","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2007,5]]}}}